![]() Price Action: DGX shares are down 4.35% at $138.61 on the last check Wednesday. The company forecasts adjusted EPS of $8.50-$8.90 compared to the consensus of $8.69 and the prior guidance of $8.45-$8.95. The company sees COVID-19 testing revenues of approximately $200 million versus $150 million - $200 million expected earlier. It is one of many ways to value QUEST DIAGNOSTICS and is calculated by multiplying the price of the stock by the number of shares issued. Market Capitalization is the total market value of QUEST DIAGNOSTICSs equity. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to. QUEST DIAGNOSTICS Market Capitalization is currently at 17.39 B. This makes Fujifilm the world's 723th most valuable company by market cap according to our data. The guidance includes base business revenues of $8.92 billion-$9.02 billion compared to the previous range of $8.78 billion-$8.88 billion. As of September 2023 Fujifilm has a market cap of 24.07 Billion. consensus of $9.06 billion and prior guidance of $8.93 billion-$9.08 billion. (NYSE: DGX) Quest Diagnosticss market cap is 14.86B, as of Aug 26, 2023. Outlook: Quest Diagnostics revises FY23 revenue guidance to $9.12 billion-$9.22 billion vs. We compare DGX and MCK because they both are industry peers, but how do you decide Three Things. ![]() A company’s total debt is the sum of all current and non-current debts. DGX market cap: 19 Bil MCK market cap: 31 Bil. According to Quest Diagnostics 's latest financial reports the company's total debt is 4.95 B. We are particularly encouraged by revenue growth in our base business of nearly ten percent from our health system customers." Quest Diagnostics (DGX) - Total debt Total debt on the balance sheet as of June 2023 : 4.95 B. Quest Diagnostics The company launched a new service in late 2016 that combines IBM s Watson cognitive computing technology with genomic tumor sequencing. Demand for our services remained strong, boosted by the collaborations we have forged with health plans, hospitals, and physicians amid a continued return to care. Jim Davis, Chairman, CEO & President, commented, "We had strong base business performance in the second quarter, with nearly double-digit revenue growth year over year.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |